{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["antioxidants", "cancer survivorship", "cancer therapy-induced side effects", "chemotherapy-induced peripheral neuropathy", "neuropathic pain", "oxidative stress", "ozone therapy", "pain"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "36111149", "DateRevised": {"Year": "2022", "Month": "09", "Day": "17"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2022", "Month": "08", "Day": "30"}], "ELocationID": ["935269", "10.3389/fphys.2022.935269"], "Journal": {"ISSN": "1664-042X", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in physiology", "ISOAbbreviation": "Front Physiol"}, "ArticleTitle": "Long-term improvement by ozone treatment in chronic pain secondary to chemotherapy-induced peripheral neuropathy: A preliminary report.", "Pagination": {"StartPage": "935269", "MedlinePgn": "935269"}, "Abstract": {"AbstractText": ["<b>Background:</b> Pain secondary to chemotherapy-induced peripheral neuropathy (CIPN) can limit the administration of chemotherapy, cancer-treatment outcomes, and the quality of life of patients. Oxidative stress and inflammation are some of the key mechanisms involved in CIPN. Successful treatments for CIPN are limited. This report shows our preliminary experience using ozone treatment as a modulator of oxidative stress in chronic pain secondary to CIPN. <b>Methods:</b> Ozone treatment, by rectal insufflation, was administered in seven patients suffering from pain secondary to grade II or III CIPN. Pain was assessed by the visual analog scale (VAS). <b>Results:</b> All patients, except one, showed clinically relevant pain improvement. Median pain score according to the VAS was 7 (range: 5-8) before ozone treatment, 4 (range: 2-6) at the end of ozone treatment (<i>p</i> = 0.004), 5.5 (range: 1.8-6.3) 3\u00a0months after the end of ozone treatment (<i>p</i> = 0.008), and 6 (range: 2.6-6.6) 6\u00a0months after the end of ozone treatment (<i>p</i> = 0.008). The toxicity grade, according to the Common Terminology Criteria for Adverse Events (CTCAE v.5.0), improved in half of the patients. <b>Conclusion:</b> This report shows that most patients obtained clinically relevant and long-lasting improvement in chronic pain secondary to CIPN after treatment with ozone. These observed effects merit further research and support our ongoing randomized clinical trial (NCT04299893)."], "CopyrightInformation": "Copyright \u00a9 2022 Clavo, Rodr\u00edguez-Abreu, Galv\u00e1n, Federico, Mart\u00ednez-S\u00e1nchez, Ramallo-Fari\u00f1a, Antonelli, Ben\u00edtez, Rey-Baltar, Jorge, Rodr\u00edguez-Esparrag\u00f3n and Serrano-Aguilar."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Unit, Hospital Universitario de Gran Canaria Dr. Negr\u00edn, Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Chronic Pain Unit, Dr. Negr\u00edn University Hospital, Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Radiation Oncology Department, Hospital Universitario Dr. Negr\u00edn, Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n Sanitaria de Canarias (FIISC), Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Molecular and Translational Pharmacology Group, Universitary Institute for Research in Biomedicine and Health (iUIBS), University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Instituto Universitario de Enfermedades Tropicales y Salud P\u00fablica de Canarias de la Universidad de La Laguna, Tenerife, Spain."}, {"Identifier": [], "Affiliation": "Research Network on Health Services in Chronic Diseases (REDISSEC), Instituto de Salud Carlos III, Madrid, Spain."}, {"Identifier": [], "Affiliation": "CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain."}, {"Identifier": [], "Affiliation": "Spanish Group of Clinical Research in Radiation Oncology (GICOR), Madrid, Spain."}], "LastName": "Clavo", "ForeName": "Bernardino", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Oncology Department, Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, Las Palmas de Gran Canaria, Spain."}], "LastName": "Rodr\u00edguez-Abreu", "ForeName": "Delvys", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Oncology Department, Hospital Universitario de Gran Canaria Dr. Negr\u00edn, Las Palmas de Gran Canaria, Spain."}], "LastName": "Galv\u00e1n", "ForeName": "Saray", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Radiation Oncology Department, Hospital Universitario Dr. Negr\u00edn, Las Palmas de Gran Canaria, Spain."}], "LastName": "Federico", "ForeName": "Mario", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Scientific Advisor, Freelance, Ancona, Italy."}], "LastName": "Mart\u00ednez-S\u00e1nchez", "ForeName": "Gregorio", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n Sanitaria de Canarias (FIISC), Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Research Network on Health Services in Chronic Diseases (REDISSEC), Instituto de Salud Carlos III, Madrid, Spain."}, {"Identifier": [], "Affiliation": "Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Tenerife, Spain."}], "LastName": "Ramallo-Fari\u00f1a", "ForeName": "Yolanda", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Oncology Department, Hospital Universitario de Gran Canaria Dr. Negr\u00edn, Las Palmas de Gran Canaria, Spain."}], "LastName": "Antonelli", "ForeName": "Carla", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Oncology Department, Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, Las Palmas de Gran Canaria, Spain."}], "LastName": "Ben\u00edtez", "ForeName": "Gretel", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Radiation Oncology Department, Hospital Universitario Dr. Negr\u00edn, Las Palmas de Gran Canaria, Spain."}], "LastName": "Rey-Baltar", "ForeName": "Dolores", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chronic Pain Unit, Dr. Negr\u00edn University Hospital, Las Palmas de Gran Canaria, Spain."}], "LastName": "Jorge", "ForeName": "Ignacio J", "Initials": "IJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Unit, Hospital Universitario de Gran Canaria Dr. Negr\u00edn, Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n Sanitaria de Canarias (FIISC), Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Instituto Universitario de Enfermedades Tropicales y Salud P\u00fablica de Canarias de la Universidad de La Laguna, Tenerife, Spain."}, {"Identifier": [], "Affiliation": "CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain."}], "LastName": "Rodr\u00edguez-Esparrag\u00f3n", "ForeName": "Francisco", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Network on Health Services in Chronic Diseases (REDISSEC), Instituto de Salud Carlos III, Madrid, Spain."}, {"Identifier": [], "Affiliation": "Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Tenerife, Spain."}, {"Identifier": [], "Affiliation": "Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de Salud (SESCS), Santa Cruz de Tenerife, Spain."}, {"Identifier": [], "Affiliation": "Red de Agencias de Evaluaci\u00f3n de Tecnolog\u00edas Sanitarias y Prestaciones del Sistema Nacional de Salud (RedETS), Madrid, Spain."}], "LastName": "Serrano-Aguilar", "ForeName": "Pedro", "Initials": "P"}], "DataBankList": [{"DataBankName": "ClinicalTrials.gov", "AccessionNumberList": ["NCT04299893"]}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Physiol", "NlmUniqueID": "101549006", "ISSNLinking": "1664-042X"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bae E. H., Greenwald M. K., Schwartz A. G. (2021). Chemotherapy-induced peripheral neuropathy: Mechanisms and therapeutic avenues. Neurotherapeutics 18 (4), 2384\u20132396. 10.1007/s13311-021-01142-2", "ArticleIdList": ["10.1007/s13311-021-01142-2", "PMC8804039", "34676514"]}, {"Citation": "Calabrese E. J., Kozumbo W. J. (2021). The hormetic dose-response mechanism: Nrf2 activation. Pharmacol. Res. 167, 105526. 10.1016/j.phrs.2021.105526", "ArticleIdList": ["10.1016/j.phrs.2021.105526", "33667690"]}, {"Citation": "Clavo B., Ceballos D., Gutierrez D., Rovira G., Suarez G., Lopez L., et al. (2013a). Long-term control of refractory hemorrhagic radiation proctitis with ozone therapy. J. Pain Symptom Manage. 46 (1), 106\u2013112. 10.1016/j.jpainsymman.2012.06.017", "ArticleIdList": ["10.1016/j.jpainsymman.2012.06.017", "23102757"]}, {"Citation": "Clavo B., Gutierrez D., Martin D., Suarez G., Hernandez M. A., Robaina F. (2005). Intravesical ozone therapy for progressive radiation-induced hematuria. J. Altern. Complement. Med. 11 (3), 539\u2013541. 10.1089/acm.2005.11.539", "ArticleIdList": ["10.1089/acm.2005.11.539", "15992242"]}, {"Citation": "Clavo B., Martinez-Sanchez G., Rodriguez-Esparragon F., Rodriguez-Abreu D., Galvan S., Aguiar-Bujanda D., et al. (2021a). Modulation by ozone therapy of oxidative stress in chemotherapy-induced peripheral neuropathy: The background for a randomized clinical trial. Int. J. Mol. Sci. 22 (6), 2802. 10.3390/ijms22062802", "ArticleIdList": ["10.3390/ijms22062802", "PMC7998838", "33802143"]}, {"Citation": "Clavo B., Navarro M., Federico M., Borrelli E., Jorge I. J., Ribeiro I., et al. (2021b). Long-term results with adjuvant ozone therapy in the management of chronic pelvic pain secondary to cancer treatment. Pain Med. 22 (9), 2138\u20132141. 10.1093/pm/pnaa459", "ArticleIdList": ["10.1093/pm/pnaa459", "PMC8557383", "33738491"]}, {"Citation": "Clavo B., Rodriguez-Esparragon F., Rodriguez-Abreu D., Martinez-Sanchez G., Llontop P., Aguiar-Bujanda D., et al. (2019). Modulation of oxidative stress by ozone therapy in the prevention and treatment of chemotherapy-induced toxicity: Review and prospects. Antioxidants (Basel) 8 (12), E588. 10.3390/antiox8120588", "ArticleIdList": ["10.3390/antiox8120588", "PMC6943601", "31779159"]}, {"Citation": "Clavo B., Santana-Rodriguez N., Gutierrez D., Lopez J. C., Suarez G., Lopez L., et al. (2013b). Long-term improvement in refractory headache following ozone therapy. J. Altern. Complement. Med. 19 (5), 453\u2013458. 10.1089/acm.2012.0273", "ArticleIdList": ["10.1089/acm.2012.0273", "23215625"]}, {"Citation": "Clavo B., Santana-Rodriguez N., Llontop P., Gutierrez D., Ceballos D., Mendez C., et al. (2015). Ozone therapy in the management of persistent radiation-induced rectal bleeding in prostate cancer patients. Evid. Based. Complement. Altern. Med. 2015, 480369. 10.1155/2015/480369", "ArticleIdList": ["10.1155/2015/480369", "PMC4556325", "26357522"]}, {"Citation": "Clavo B., Suarez G., Aguilar Y., Gutierrez D., Ponce P., Cubero A., et al. (2011). Brain ischemia and hypometabolism treated by ozone therapy. Forsch. Komplementmed. 18 (5), 283\u2013287. 10.1159/000333795", "ArticleIdList": ["10.1159/000333795", "22105041"]}, {"Citation": "Dhawan S., Andrews R., Kumar L., Wadhwa S., Shukla G. (2020). A randomized controlled trial to assess the effectiveness of muscle strengthening and balancing exercises on chemotherapy-induced peripheral neuropathic pain and quality of life among cancer patients. Cancer Nurs. 43 (4), 269\u2013280. 10.1097/NCC.0000000000000693", "ArticleIdList": ["10.1097/NCC.0000000000000693", "30888982"]}, {"Citation": "Di Cesare Mannelli L., Zanardelli M., Failli P., Ghelardini C. (2012). Oxaliplatin-induced neuropathy: Oxidative stress as pathological mechanism. Protective effect of silibinin. J. Pain 13 (3), 276\u2013284. 10.1016/j.jpain.2011.11.009", "ArticleIdList": ["10.1016/j.jpain.2011.11.009", "22325298"]}, {"Citation": "Fuccio C., Luongo C., Capodanno P., Giordano C., Scafuro M. A., Siniscalco D., et al. (2009). A single subcutaneous injection of ozone prevents allodynia and decreases the over-expression of pro-inflammatory caspases in the orbito-frontal cortex of neuropathic mice. Eur. J. Pharmacol. 603 (1-3), 42\u201349. 10.1016/j.ejphar.2008.11.060", "ArticleIdList": ["10.1016/j.ejphar.2008.11.060", "19100257"]}, {"Citation": "Galie M., Covi V., Tabaracci G., Malatesta M. (2019). The role of Nrf2 in the antioxidant cellular response to medical ozone exposure. Int. J. Mol. Sci. 20 (16), E4009. 10.3390/ijms20164009", "ArticleIdList": ["10.3390/ijms20164009", "PMC6720777", "31426459"]}, {"Citation": "Guclu A., Erken H. A., Erken G., Dodurga Y., Yay A., Ozcoban O., et al. (2016). The effects of ozone therapy on caspase pathways, TNF-\u03b1, and HIF-1\u03b1 in diabetic nephropathy. Int. Urol. Nephrol. 48 (3), 441\u2013450. 10.1007/s11255-015-1169-8", "ArticleIdList": ["10.1007/s11255-015-1169-8", "26614261"]}, {"Citation": "Hidalgo-Tallon F. J., Torres-Morera L. M., Baeza-Noci J., Carrillo-Izquierdo M. D., Pinto-Bonilla R. (2022). Updated review on ozone therapy in pain medicine. Front. Physiol. 13, 840623. 10.3389/fphys.2022.840623", "ArticleIdList": ["10.3389/fphys.2022.840623", "PMC8904924", "35283802"]}, {"Citation": "Kleckner I. R., Kamen C., Gewandter J. S., Mohile N. A., Heckler C. E., Culakova E., et al. (2018). Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: A multicenter, randomized controlled trial. Support. Care Cancer 26 (4), 1019\u20131028. 10.1007/s00520-017-4013-0", "ArticleIdList": ["10.1007/s00520-017-4013-0", "PMC5823751", "29243164"]}, {"Citation": "Kneis S., Wehrle A., Muller J., Maurer C., Ihorst G., Gollhofer A., et al. (2019). It's never too late - balance and endurance training improves functional performance, quality of life, and alleviates neuropathic symptoms in cancer survivors suffering from chemotherapy-induced peripheral neuropathy: Results of a randomized controlled trial. BMC Cancer 19 (1), 414. 10.1186/s12885-019-5522-7", "ArticleIdList": ["10.1186/s12885-019-5522-7", "PMC6498676", "31046719"]}, {"Citation": "Kruk J., Aboul-Enein H. Y., Kladna A., Bowser J. E. (2019). Oxidative stress in biological systems and its relation with pathophysiological functions: The effect of physical activity on cellular redox homeostasis. Free Radic. Res. 53 (5), 497\u2013521. 10.1080/10715762.2019.1612059", "ArticleIdList": ["10.1080/10715762.2019.1612059", "31039624"]}, {"Citation": "Loprinzi C. L., Lacchetti C., Bleeker J., Cavaletti G., Chauhan C., Hertz D. L., et al. (2020). Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J. Clin. Oncol. 38 (28), 3325\u20133348. 10.1200/JCO.20.01399", "ArticleIdList": ["10.1200/JCO.20.01399", "32663120"]}, {"Citation": "Markham M. J., Wachter K., Agarwal N., Bertagnolli M. M., Chang S. M., Dale W., et al. (2020). Clinical cancer advances 2020: Annual report on progress against cancer from the American society of clinical oncology. J. Clin. Oncol. 38 (10), 1081. 10.1200/JCO.19.03141", "ArticleIdList": ["10.1200/JCO.19.03141", "32013670"]}, {"Citation": "Re L., Martinez-Sanchez G., Bordicchia M., Malcangi G., Pocognoli A., Morales-Segura M. A., et al. (2014). Is ozone pre-conditioning effect linked to nrf2/EpRE activation pathway in vivo? A preliminary result. Eur. J. Pharmacol. 742, 158\u2013162. 10.1016/j.ejphar.2014.08.029", "ArticleIdList": ["10.1016/j.ejphar.2014.08.029", "25218903"]}, {"Citation": "Salat K. (2020). Chemotherapy-induced peripheral neuropathy: Part 1-current state of knowledge and perspectives for pharmacotherapy. Pharmacol. Rep. 72 (3), 486\u2013507. 10.1007/s43440-020-00109-y", "ArticleIdList": ["10.1007/s43440-020-00109-y", "PMC7329796", "32394362"]}, {"Citation": "Seretny M., Currie G. L., Sena E. S., Ramnarine S., Grant R., MacLeod M. R., et al. (2014). Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain 155 (12), 2461\u20132470. 10.1016/j.pain.2014.09.020", "ArticleIdList": ["10.1016/j.pain.2014.09.020", "25261162"]}, {"Citation": "Shim H. S., Bae C., Wang J., Lee K. H., Hankerd K. M., Kim H. K., et al. (2019). Peripheral and central oxidative stress in chemotherapy-induced neuropathic pain. Mol. Pain 15, 1744806919840098. 10.1177/1744806919840098", "ArticleIdList": ["10.1177/1744806919840098", "PMC6458664", "30857460"]}, {"Citation": "Smith E. M., Pang H., Cirrincione C., Fleishman S., Paskett E. D., Ahles T., et al. (2013). Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: A randomized clinical trial. JAMA 309 (13), 1359\u20131367. 10.1001/jama.2013.2813", "ArticleIdList": ["10.1001/jama.2013.2813", "PMC3912515", "23549581"]}, {"Citation": "Starobova H., Vetter I. (2017). Pathophysiology of chemotherapy-induced peripheral neuropathy. Front. Mol. Neurosci. 10, 174. 10.3389/fnmol.2017.00174", "ArticleIdList": ["10.3389/fnmol.2017.00174", "PMC5450696", "28620280"]}, {"Citation": "Tricarico G., Travagli V. (2021). The relationship between ozone and human blood in the course of a well-controlled, mild, and transitory oxidative eustress. Antioxidants (Basel) 10 (12), 1946. 10.3390/antiox10121946", "ArticleIdList": ["10.3390/antiox10121946", "PMC8750071", "34943049"]}, {"Citation": "Viebahn-Haensler R., Leon Fernandez O. S. (2021). Ozone in medicine. The low-dose ozone concept and its basic biochemical mechanisms of action in chronic inflammatory diseases. Int. J. Mol. Sci. 22 (15), 7890. 10.3390/ijms22157890", "ArticleIdList": ["10.3390/ijms22157890", "PMC8346137", "34360655"]}, {"Citation": "Viebahn-Hansler R., Leon Fernandez O. S., Fahmy Z. (2016). Ozone in medicine: Clinical evaluation and evidence classification of the systemic ozone applications, major autohemotherapy and rectal insufflation, according to the requirements for evidence-based medicine. Ozone Sci. Eng. 38, 322\u2013345. 10.1080/01919512.2016.1191992", "ArticleIdList": ["10.1080/01919512.2016.1191992"]}, {"Citation": "Wu M. Y., Xing C. Y., Wang J. N., Li Y., Lin X. W., Fu Z. J. (2018). Therapeutic dosage of ozone inhibits autophagy and apoptosis of nerve roots in a chemically induced radiculoneuritis rat model. Eur. Rev. Med. Pharmacol. Sci. 22 (6), 1787\u20131797. 10.26355/eurrev_201803_14598", "ArticleIdList": ["10.26355/eurrev_201803_14598", "29630128"]}, {"Citation": "Zajaczkowska R., Kocot-Kepska M., Leppert W., Wrzosek A., Mika J., Wordliczek J. (2019). Mechanisms of chemotherapy-induced peripheral neuropathy. Int. J. Mol. Sci. 20 (6), E1451. 10.3390/ijms20061451", "ArticleIdList": ["10.3390/ijms20061451", "PMC6471666", "30909387"]}, {"Citation": "Zhang S. (2021). Chemotherapy-induced peripheral neuropathy and rehabilitation: A review. Semin. Oncol. 48 (3), 193\u2013207. 10.1053/j.seminoncol.2021.09.004", "ArticleIdList": ["10.1053/j.seminoncol.2021.09.004", "34607709"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "5", "Day": "3"}, {"Year": "2022", "Month": "8", "Day": "9"}, {"Year": "2022", "Month": "9", "Day": "16", "Hour": "2", "Minute": "43"}, {"Year": "2022", "Month": "9", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "17", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "8", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["36111149", "PMC9468657", "10.3389/fphys.2022.935269", "935269"]}}], "PubmedBookArticle": []}